The longstanding relationship between 4DMedcial and its primary research and academic partner, the University of Melbourne, has been formalised through signing of a Memorandum of Understanding (MoU).  The two organisations collaborate in a number of spheres that will widen to include use of XV Technology... Read More »
MD/CEO Dr Andreas Fouras talks revenue growth, clinical trials validating technological application and commercial piloting expansion successes during FY2021-22 in interview with Nadine Blayney on ausbiz 19 AUG 2022. Read More »
At 4DMedical we are acutely aware of the debt owed to so many United States serving and former military personnel.  The passing of the Sergeant First Class Heath Robinson Honoring Our PACT Act of 2022 (“PACT Act”) this week by Congress recognises the tragic legacy... Read More »
We commend Congress for passing this critical legislation. The PACT Act ensures veterans exposed to toxic substances and airborne hazards during service will have access to healthcare technologies and disability benefits specific to their conditions. Read More »
VA to evaluate “emerging technology using existing x-ray imaging equipment to derive four-dimensional models of lung function.” Four-dimensional scanning software is one of those “emerging technologies” available right now to help veterans suffering from respiratory illness. Read More »
Announcement of Johns Hopkins clinical trial results and presentation at ATS 2022 reported in BiotechDespatch.   Read More »